Abbott recalls some ready-to-feed baby formula liquid products including Similac

Published On 2022-10-15 06:45 GMT   |   Update On 2022-10-15 06:45 GMT
Advertisement

New Delhi: Abbott Laboratories said on Friday it was recalling some ready-to-feed baby formula liquid products including Similac-branded items due to inadequate sealing of some bottle caps.

The recall, which equates to less than one day's worth of infant formula used in the United States, is not expected to impact the overall formula supply, Abbott said in a statement.

Abbott has been at the center of a baby formula shortage in the United States that earlier this year sent parent scrambling for supplies.

Advertisement

The recall of baby formula made at Abbott's Michigan plant following complaints of bacterial infection in February exacerbated its shortage in the United States.

Read also: Abbott labs India unit concludes recall of baby formula products manufactured at Michigan facility

To boost supplies, the U.S. government temporarily allowed foreign imports from companies such as Reckitt Benckiser and Nestle.

Supplies have been improving in recent months, according to large retailers such as Walmart, but the government has continued to allow imports to stock up shelves.

Read also: Abbott restarts Similac infant formula production at Michigan facility

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News